TrialCPT: pharmacometrics & systems pharmacology2022

Multi-model averaging improves the performance of model-guided infliximab dosing in patients with inflammatory bowel diseases.

Wannee Kantasiripitak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.